Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
Category: Cholesterol
-
The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists
The New York Times – Business: -
A Promising Heart Drug Fails, Challenging a Long-Held Theory of Disease
The New York Times – Business:The drug targeted inflammation, and its shocking failure has experts questioning whether inflammation really does cause heart disease.
-
Deaths Linked to Japanese Supplement Suddenly Rise to 80
The case, involving a supplement intended to reduce cholesterol, has put attention on how companies are allowed to self-report claims about their products.